DGAP-News

MeVis Medical Solutions AG: Preliminary figures 2013: MeVis forecast fully met / First guidance for 2014

DGAP-News: MeVis Medical Solutions AG / Key word(s): Preliminary
Results/Forecast
MeVis Medical Solutions AG: Preliminary figures 2013: MeVis forecast
fully met / First guidance for 2014

05.03.2014 / 07:30

---------------------------------------------------------------------

2013 strongest year since IPO in 2007

- Group revenues increased by 10 % year on year to EUR 14.6 m

- Earnings before interest and taxes (EBIT) increased significantly by
EUR 1.0 m to EUR 4,0 m

- Liquidity increased by EUR 5.3 m to EUR 14.0 m (Dec.31, 2012: EUR 8.7
m)

- Guidance for 2014 (starting 2014 MBC will be consolidated at-equity and
not proportionally):

- Revenues between EUR 12.0 m and EUR 12.5 m

- EBIT between EUR 3.0 m and EUR 3.5 m

- Liquidity between EUR 15 m and EUR 16 m by the end of 2014

Bremen, March 5, 2014 - MeVis Medical Solutions AG [ISIN: DE000A0LBFE4], a
leading provider of medical imaging software, today announced its
preliminary figures for fiscal year 2013.

The group revenues generated in 2013 amounted to EUR 14.6 m, up 10 %
compared to the previous year's revenues of EUR 13.3 m. The increase in
licensing business by 11 % from EUR 6.9 m to EUR 7.7 m as well as an
increase in non-recurring engineering contrbutions of EUR 0.5 m to EUR 1.0
m contributed to this growth. Maintenance revenues remained stable at EUR
5.9 m.

The increase in revenues resulted almost entirely from the Digital
Mammography segment, where revenues rose from EUR 10.1 m to EUR 11.3 m,
while revenues in the Other Diagnostics segment rose only marginally from
EUR 3.2 m to EUR 3.3 m.

Operating costs could be reduced again in 2013 as staff costs decreased by
EUR 0.2 m from EUR 8.1 m to EUR 7.9 m and other operating expenses by as
much as EUR 0.4 m from EUR 2.3 m to EUR 1.9 m.

In 2013 the capitalization of development costs has been cut nearly in half
by EUR 1.0 m from EUR 2.4 m to EUR 1.4 m. This effect is almost entirely
offset by a decrease in depreciation of EUR 0.9 m from EUR 3.0 m to EUR 2.1
m.

For 2013 this results in an EBIT (earnings before interest and taxes) of
EUR 4.0 m, which is EUR 1.0 m higher than previous year and corresponds to
an EBIT margin of 27 % (previous year: 21 %).

Cash and cash equivalents increased significantly in 2013 and amounted to
EUR 14.0 m at year-end (compared to EUR 8.7 m as at December 31, 2012). In
addition to the good operating performance the reduction of receivables has
been instrumental to this very strong cash flow of EUR 5.3 m.

"We are pleased with the very positive development in 2013. In 2014, in